Introduction: Orthodontists traditionally have used various compliance-dependent physical means such as headgears and various intraoral appliances to prevent anchorage loss. The aim of this study was to determine if local application of the bisphosphonate zoledronate could be used to prevent anchorage loss during extraction space closure in rats. Methods: The upper left 1st molar was extracted and the upper left 2nd molar was protracted into the extraction space with a 10g NiTi closing coil for 21 days. Fifteen controls received a local injection of phosphate-buffered saline, while fifteen experimentals received 16 g of the bisphosphonate zoledronate. The solution was also delivered directly into the extraction site and left undisturb...
Background. Anchorage control is an essential part of orthodontic treatment planning, especially in ...
Abstract Antiresorptive or antiangiogenic drugs can cause medication-related osteonecrosis of the ja...
Introduction: The effect of zoledronic acid, a potent and novel bisphosphonate, on tooth movement an...
INTRODUCTION: The aim of this pilot study was to investigate the effect of long-term bisphosphonate...
BACKGROUND: This work aimed at determining whether bisphosphonate therapy produces a sufficient cond...
Osteonecrosis of the jaw induced by administration of bisphosphonates (BPs), BP-related osteonecrosi...
The aim of this study was to evaluate a novel animal model of bisphosphonates-associated osteonecros...
Osteonecrosis of the jaw induced by administration of bisphosphonates (BPs), BP-related osteonecrosi...
Introduction: The effect of zoledronic acid, a potent and novel bisphosphonate, on tooth movement an...
Background: Bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) disease is rare, but there ...
Medication related osteonecrosis of the Jaws (MRONJ) is a severe complication of antiresorptive and ...
Introduction: The effect of zoledronic acid, a potent and novel bisphosphonate, on tooth movement an...
Patients with osteoporosis and joint disabilities represent a constant growing and challenging popul...
Patients with osteoporosis and joint disabilities represent a constant growing and challenging popul...
We evaluated the side effects of bisphosphonate (BP) on tooth extraction socket healing in spontaneo...
Background. Anchorage control is an essential part of orthodontic treatment planning, especially in ...
Abstract Antiresorptive or antiangiogenic drugs can cause medication-related osteonecrosis of the ja...
Introduction: The effect of zoledronic acid, a potent and novel bisphosphonate, on tooth movement an...
INTRODUCTION: The aim of this pilot study was to investigate the effect of long-term bisphosphonate...
BACKGROUND: This work aimed at determining whether bisphosphonate therapy produces a sufficient cond...
Osteonecrosis of the jaw induced by administration of bisphosphonates (BPs), BP-related osteonecrosi...
The aim of this study was to evaluate a novel animal model of bisphosphonates-associated osteonecros...
Osteonecrosis of the jaw induced by administration of bisphosphonates (BPs), BP-related osteonecrosi...
Introduction: The effect of zoledronic acid, a potent and novel bisphosphonate, on tooth movement an...
Background: Bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) disease is rare, but there ...
Medication related osteonecrosis of the Jaws (MRONJ) is a severe complication of antiresorptive and ...
Introduction: The effect of zoledronic acid, a potent and novel bisphosphonate, on tooth movement an...
Patients with osteoporosis and joint disabilities represent a constant growing and challenging popul...
Patients with osteoporosis and joint disabilities represent a constant growing and challenging popul...
We evaluated the side effects of bisphosphonate (BP) on tooth extraction socket healing in spontaneo...
Background. Anchorage control is an essential part of orthodontic treatment planning, especially in ...
Abstract Antiresorptive or antiangiogenic drugs can cause medication-related osteonecrosis of the ja...
Introduction: The effect of zoledronic acid, a potent and novel bisphosphonate, on tooth movement an...